Delta 9-tetrahydrocannabinol: elevation of absolute visual thresholds of rabbits. (abst – 1979)                               


Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.        (abst – 1981)


Ocular Effects of Topical Administration of {Delta}9-Tetrahydrocannabinol in Man (full – 1982)

http://archopht.ama- hid=1&FIRSTINDEX=2960&resourcetype=HWCIT


Mydriasis induced by tetrahydrocannabinol (THC) in rats                      (full – 1982) a&searchid=1&FIRSTINDEX=640&resourcetype=HWCIT


Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9- tetrahydrocannabinol or cannabichromene.                                                               (abst – 1984)


Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.                                               (abst – 1984)


Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.                                               (abst – 1984)


Persistent visual changes following hashish consumption.                     (full – 1993)


HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy.                                                        (abst – 1996)


Patent 5631297 – Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same

(full – 1997)    


Smoking dope restored my sight                 (news/anecdotal – 1998)


Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.                                                  (abst – 1999)


Links found between marijuana and vision                (news – 1999)


Cannabinoids’ Role In Retinal Function Described                (news – 1999)


Different effects of nabilone and cannabidiol on binocular depth inversion in Man. (abst – 2000)                          


Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d- Aspartate-Induced Retinal Neurotoxicity – Involvement of Peroxynitrite                                                            (full – 2003)


Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury.                                                     (abst – 2003)


Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco                                                                         (full – 2004)



Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes     (abst – 2004)  xt=cannabinoid&searchid=1&FIRSTINDEX=1760&resourcetype=HWCIT


When spliff gets in your eyes…             (news – 2004)


In-vitro corneal permeation of cannabinoids and their water-soluble phosphate ester prodrugs.     (abst – 2005)                   


Marijuna Cured My Color-Blindness               (anecdotal – 2005


Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full – 2006)


R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase- 2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells.

(full – 2006)     


Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.                                                       (abst – 2006)


Marijuana Compound May Help Stop Diabetic Retinopathy              (news – 2006)


Getting Eye On Cannabinoids              (news – 2006)


Marijuana compound could prevent eye damage in diabetics               (news – 2006)   n_diabetics


Endocannabinoids in the retina: From marijuana to neuroprotection.  (full – 2008)


Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.        (full – 2008)


Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.                                                     (full – 2008)


Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor                                                (full – 2008)


Reduction of Congenital Nystagmus in a Patient after Smoking Cannabis. (abst – 2008) yst  agmus_in_a_Patient_after_Smoking_Cannabis_


Assessing changes in pupillary size in Rifian smokers of kif (Cannabis sativa L.). (abst – 2008)                        


The role of endocannabinoid system in physiological and pathological processes in the eye           (abst – 2008) noid_system_in_physiological_and_pathological_processes_in_the_eye%5D


Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full – 2009)


Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.           (full – 2009)           


Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.        (full – 2010)


Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. (full– 2010)                          


Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization   (link to PDF – 2010) ll&recNo=68&uiLanguage=en


Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.         (abst – 2010)                            


Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization   (abst – 2010)  133%29%20therapy%20could%20be%20effective%20for%20treatment%20of%20corneal%20neovascular ization%20&f1=all&b1=and&q2=&f2=all&recNo=1&uiLanguage=en


Are There Any Herbal Supplements to Reduce Intraocular Pressure?               (news – 2010)  pressure/#ixzz21Iz6sfdN


Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study.                                                                   (full – 2011)


Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism.                                              (full – 2011)


2-Arachidonoylglycerol (2-AG) Induces Corneal Epithelial Cell Migration via Cannabinoid CB1 Receptors                                                            (abst – 2011)  ext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT


Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011)                              


Comparison Of Rat And Human Eyes For The Presence And Distribution Of Cb1 And Cb2 Receptors   (abst – 2011) ext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT


Enhanced solubility, stability, and transcorneal permeability of delta-8- tetrahydrocannabinol in the presence of cyclodextrins.

(abst – 2011)      


Indirect Sympatholytic Actions at β-Adrenoceptors Account for the Ocular Hypotensive Actions of Cannabinoid Receptor Agonists                                                         (abst – 2011)


Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure.

(abst – 2011)     


Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys.                                                    (abst – 2012)


Effects of Palmitoylethanolamide on Aqueous Humor Outflow.             (abst – 2012)


Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.                                                (abst – 2012)


Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.                                                                 (abst – 2012)


Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.                                                          (abst – 2012)


Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow- enhancing effects of abnormal-cannabidiol.                                                   (abst – 2012)


Developmental and Visual Input-Dependent Regulation of the CB1 Cannabinoid Receptor in the Mouse Visual Cortex.                                                               (full – 2013)


Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle                                                    (abst – 2013)

Share a link for